Related references
Note: Only part of the references are listed.Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Shinichi Yachida et al.
CANCER DISCOVERY (2022)
Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation? Comment
Ilaria Marinoni
GUT (2022)
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
Wenzel M. Hackeng et al.
GUT (2022)
Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis
Mohamad Bassam Sonbol et al.
ONCOLOGIST (2022)
Surgery vs Observation for Patients With Small Pancreatic Neuroendocrine Tumors
Hassan Aziz et al.
JAMA SURGERY (2021)
The C-Circle Biomarker Is Secreted by Alternative-Lengthening-of-Telomeres Positive Cancer Cells inside Exosomes and Provides a Blood-Based Diagnostic for ALT Activity
Yuan-Yin Chen et al.
CANCERS (2021)
ALT Positivity in Human Cancers: Prevalence and Clinical Insights
Danny MacKenzie et al.
CANCERS (2021)
ID: 3526413 ALTERNATIVE LENGTHENING OF TELOMERES AND LOSS OF DAXX/ATRX EXPRESSION IN PANCREATIC NEUROENDOCRINE TUMORS FROM ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION (EUS-FNA) SPECIMENS CORRELATE WITH POOR PATIENT SURVIVAL
Neha Singh et al.
GASTROINTESTINAL ENDOSCOPY (2021)
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Manisha H. Shah et al.
Journal of the National Comprehensive Cancer Network (2021)
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
Claudio Luchini et al.
CURRENT ONCOLOGY REPORTS (2021)
Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database
Hussein A. Assi et al.
ONCOLOGIST (2020)
Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration
Wenzel M. Hackeng et al.
DIAGNOSTIC CYTOPATHOLOGY (2020)
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
Thorvardur R. Halfdanarson et al.
PANCREAS (2020)
Performance of DAXX Immunohistochemistry as a Screen for DAXX Mutations in Pancreatic Neuroendocrine Tumors
Jaclyn F. Hechtman et al.
PANCREAS (2019)
TelomereHunter - in silico estimation of telomere content and composition from cancer genomes
Lars Feuerbach et al.
BMC BIOINFORMATICS (2019)
Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases
Aatur D. Singhi et al.
HISTOPATHOLOGY (2018)
Prognosis of sporadic resected small (<= 2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study
Ville J. Sallinen et al.
HPB (2018)
Integrated Genomic Analysis of Hurthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes
Ian Ganly et al.
CANCER CELL (2018)
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann et al.
SCIENCE (2018)
Grading by the Ki-67 Labeling Index of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy Specimens of Pancreatic Neuroendocrine Tumors Can Be Underestimated
Hee Sang Hwang et al.
PANCREAS (2018)
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
Joo Young Kim et al.
CLINICAL CANCER RESEARCH (2017)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
The C-Circle Assay for alternative-lengthening-of-telomeres activity
Jeremy D. Henson et al.
METHODS (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology-Diagnosis and Prognostic Stratification
Aurel Perren et al.
NEUROENDOCRINOLOGY (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors
Christopher J. VandenBussche et al.
CANCER CYTOPATHOLOGY (2017)
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study
Eran Sadot et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas
Laura H. Tang et al.
CLINICAL CANCER RESEARCH (2016)
Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors
Irene Y. Zhang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies (vol 28, pg 686, 2015)
Michelle D. Reid et al.
MODERN PATHOLOGY (2016)
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas
Laura H. Tang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas
Jau-Yu Liau et al.
MODERN PATHOLOGY (2015)
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Lauren Fishbein et al.
NATURE COMMUNICATIONS (2015)
Computel: Computation of Mean Telomere Length from Whole-Genome Next-Generation Sequencing Data
Lilit Nersisyan et al.
PLOS ONE (2015)
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET
M. Lombardi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
ALTernative Telomere Maintenance and Cancer
Robert L. Dilley et al.
TRENDS IN CANCER (2015)
Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas A Clinicopathologic Analysis of 44 Cases
Olca Basturk et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
A Single Institution's 26-Year Experience With Nonfunctional Pancreatic Neuroendocrine Tumors A Validation of Current Staging Systems and a New Prognostic Nomogram
Trevor A. Ellison et al.
ANNALS OF SURGERY (2014)
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Ilaria Marinoni et al.
GASTROENTEROLOGY (2014)
Alternative Lengthening of Telomeres Predicts Site of Origin in Neuroendocrine Tumor Liver Metastases
Epameinondas Dogeas et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Estimating telomere length from whole genome sequence data
Zhihao Ding et al.
NUCLEIC ACIDS RESEARCH (2014)
Observational Study of Natural History of Small Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors
Sebastien Gaujoux et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features
Laura D. Wood et al.
MODERN PATHOLOGY (2013)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Shinichi Yachida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System A Comparison of Digital Image Analysis With Manual Methods
Laura H. Tang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Pancreatic neuroendocrine tumors: Clinical features, diagnosis and medical treatment: Advances
Tetsuhide Ito et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Epidemiology of gastroenteropancreatic neuroendocrine tumours
M. Fraenkel et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms
Nicholas A. Hamilton et al.
SURGERY (2012)
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
Courtney A. Lovejoy et al.
PLOS GENETICS (2012)
Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
Christopher M. Heaphy et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Implications of Incidentally Discovered, Nonfunctioning Pancreatic Endocrine Tumors Short-term and Long-term Patient Outcomes
Alex B. Haynes et al.
ARCHIVES OF SURGERY (2011)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy et al.
SCIENCE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3
Pascal Drane et al.
GENES & DEVELOPMENT (2010)
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients
Aldo Scarpa et al.
MODERN PATHOLOGY (2010)
The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas
Jonathan R. Strosberg et al.
PANCREAS (2010)
Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres
Peter W. Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression
Andrea Proctor Subhawong et al.
MODERN PATHOLOGY (2009)
DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity
Jeremy D. Henson et al.
NATURE BIOTECHNOLOGY (2009)
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2008)
Improved contemporary surgical management of insulinomas - A 25-year experience at the Massachusetts General Hospital
Mehrdad Nikfarjam et al.
ANNALS OF SURGERY (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Surgery increases survival in patients with gastrinoma
Jeffrey A. Norton et al.
ANNALS OF SURGERY (2006)
Alternative lengthening of telomeres in mammalian cells
JD Henson et al.
ONCOGENE (2002)
Share Paper
